AJP - Endo AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 257: E228-E234, 1989;
0193-1849/89 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abumrad, N. N.
Right arrow Articles by Adibi, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abumrad, N. N.
Right arrow Articles by Adibi, S. A.

AJP - Endocrinology and Metabolism, Vol 257, Issue 2 E228-E234, Copyright © 1989 by American Physiological Society

ARTICLES

Possible sources of glutamine for parenteral nutrition: impact on glutamine metabolism

N. N. Abumrad, E. L. Morse, H. Lochs, P. E. Williams and S. A. Adibi
Department of Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.

Due to its instability, glutamine is not included in solutions for parenteral solution. This problem can be obviated by providing glutamine as acetyl-, glycyl-, or alanylglutamine. Using an organ balance technique in conscious dogs, we investigated metabolism of these three sources of glutamine. Liver, gut, kidney, and muscle participated in clearance of glycyl- and alanylglutamine from plasma, but among these organs only kidney cleared acetylglutamine. Furthermore, there was a large urinary excretion for acetylglutamine (38 +/- 6% of amount infused) but only a trace amount for either dipeptide. The infusion of glutamine-dipeptides resulted in similar increases in blood level of free glutamine. The main source of this increase appeared to be hydrolysis of dipeptides by kidney and release of free glutamine to circulation. During the infusion of both dipeptides, glutamine balance (free and dipeptide forms) was always positive (net uptake) across liver, gut, and kidney but was neutral across muscle. Liver or gut glutamine balances were not significantly different during the infusion of dipeptides, but kidney glutamine balance was twofold greater during the infusion of glycyl- than alanylglutamine. We conclude that among these three sources of glutamine, acetylglutamine is least desirable for use in parenteral nutrition. Glycylglutamine may be preferable over alanylglutamine if the objective is to target glutamine for kidney.


This article has been cited by other articles:


Home page
 J. Nutr.Home page
P. Furst
New Developments in Glutamine Delivery
J. Nutr., September 1, 2001; 131(9): 2562S - 2568.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. E. Halseth, N. Rheaume, A. B. Messina, E. K. Reed, M. G. Krishna, P. J. Flakoll, D. B. Lacy, and D. H. Wasserman
Regulation of hepatic glutamine metabolism during exercise in the dog
Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E655 - E664.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
P. Fürst
Old and New Substrates in Clinical Nutrition
J. Nutr., May 1, 1998; 128(5): 789 - 796.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online